Target intelligence / Profile preview

Bacterial surface anionic polymer

Molecular classification
Glycopolymer, Polysaccharide, Cell wall component, Other
01

Overview

Bacterial surface anionic polymers are a diverse group of negatively charged glycopolymers essential for the structural integrity and physiological function of the bacterial cell envelope. In Gram-positive bacteria, these are primarily represented by wall teichoic acids (WTA) and lipoteichoic acids (LTA), whereas in Gram-negative bacteria, lipopolysaccharides (LPS) serve as the dominant anionic component (Raetz & Whitfield, 2002; Brown et al., 2013). These polymers contribute to the net negative charge of the bacterial surface, facilitating the sequestration of essential divalent cations like Mg2+ and Ca2+, which stabilize the membrane and support enzymatic activities (Brown et al., 2013). They are critical for processes such as cell wall morphogenesis, biofilm formation, and adherence to host cells during infection (Weidenmaier & Peschel, 2008). Therapeutically, these polymers are targeted by several classes of antibiotics; for instance, polymyxins bind to the lipid A component of LPS, while daptomycin's activity is linked to its interaction with LTA and the cytoplasmic membrane (Trimble et al., 2016; Heidary et al., 2018). Additionally, these molecules are potent triggers of the innate immune system, acting as ligands for Toll-like receptors (TLR2 and TLR4) to initiate inflammatory cascades (Akira & Takeda, 2004). Targeting the biosynthesis of these polymers, particularly WTAs, is an emerging strategy to restore antibiotic sensitivity in resistant strains like MRSA (Campbell et al., 2011).

Other names
Teichoic acidLipoteichoic acidLipopolysaccharideBacterial surface polyanionWall teichoic acidAcidic capsular polysaccharidePolyanionic glycopolymer
02

Mechanism of action

Drugs target these polymers through electrostatic interactions that disrupt membrane integrity or by inhibiting the biosynthetic pathways of these essential cell wall components.

03

Biological functions

Cell wall integrityIon homeostasisAdhesionBiofilm formationImmune responseOther
04

Disease associations

InfectionInflammationSepsisOther
05

Safety considerations

NephrotoxicityNeurotoxicityAntibiotic resistance developmentJarisch-Herxheimer reaction
06

Interacting drugs

Polymyxin B

5 more in the full profile.

07

Biomarkers

Endotoxin levelProcalcitoninC-reactive proteinLipoteichoic acid detection

Beyond the preview

Go deeper on Bacterial surface anionic polymer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial surface anionic polymer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call